newsfilter
← Latest News
PR Newswire·

European Medicines Agency Accepts Astellas' Marketing Authorization Application for Zolbetuximab

TOKYO, July 13, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the European Medicines Agency (EMA) has accepted for regulatory review the